157 related articles for article (PubMed ID: 2366082)
1. Cell kinetics of rat 9L brain tumors determined by double labeling with iodo- and bromodeoxyuridine.
Asai A; Shibui S; Barker M; Vanderlaan M; Gray JW; Hoshino T
J Neurosurg; 1990 Aug; 73(2):254-8. PubMed ID: 2366082
[TBL] [Abstract][Full Text] [Related]
2. [Proliferation kinetics of human brain tumors by in situ double labeling with bromodeoxyuridine and iododeoxyuridine].
Maeda T; Hoshino T
No To Shinkei; 1992 Sep; 44(9):821-5. PubMed ID: 1476811
[TBL] [Abstract][Full Text] [Related]
3. Cell kinetic analysis of human brain tumors by in situ double labelling with bromodeoxyuridine and iododeoxyuridine.
Hoshino T; Ito S; Asai A; Shibuya M; Prados MD; Dodson BA; Davis RL; Wilson CB
Int J Cancer; 1992 Jan; 50(1):1-5. PubMed ID: 1728598
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical double staining with immunogold-silver and alkaline phosphatase to identify nuclear markers of cellular proliferation.
Shibuya M; Ito S; Davis RL; Hoshino T
Biotech Histochem; 1993 Jan; 68(1):17-9. PubMed ID: 8383543
[TBL] [Abstract][Full Text] [Related]
5. Cell kinetics of glial tumors.
Hoshino T
Rev Neurol (Paris); 1992; 148(6-7):396-401. PubMed ID: 1448658
[TBL] [Abstract][Full Text] [Related]
6. A new method for analyzing the cell kinetics of human brain tumors by double labeling with bromodeoxyuridine in situ and with iododeoxyuridine in vitro.
Shibuya M; Ito S; Davis RL; Wilson CB; Hoshino T
Cancer; 1993 May; 71(10):3109-13. PubMed ID: 8490840
[TBL] [Abstract][Full Text] [Related]
7. [A review of cell kinetic studies on brain tumors with special reference to anti-bromodeoxyuridine monoclonal antibody method].
Nagashima T; Hoshino T
No Shinkei Geka; 1984 Aug; 12(9):1007-18. PubMed ID: 6390240
[TBL] [Abstract][Full Text] [Related]
8. Double labeling with iodo- and bromodeoxyuridine for cell kinetics studies.
Shibui S; Hoshino T; Vanderlaan M; Gray JW
J Histochem Cytochem; 1989 Jul; 37(7):1007-11. PubMed ID: 2659659
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous immunohistochemical detection of IUdR and BrdU infused intravenously to cancer patients.
Miller MA; Mazewski CM; Yousuf N; Sheikh Y; White LM; Yanik GA; Hyams DM; Lampkin BC; Raza A
J Histochem Cytochem; 1991 Apr; 39(4):407-12. PubMed ID: 2005370
[TBL] [Abstract][Full Text] [Related]
10. In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.
Hoshino T; Nagashima T; Murovic JA; Wilson CB; Edwards MS; Gutin PH; Davis RL; DeArmond SJ
J Neurosurg; 1986 Mar; 64(3):453-9. PubMed ID: 3950723
[TBL] [Abstract][Full Text] [Related]
11. Cell kinetics studies of human brain tumors by in vitro labeling using anti-BUdR monoclonal antibody.
Nishizaki T; Orita T; Saiki M; Furutani Y; Aoki H
J Neurosurg; 1988 Sep; 69(3):371-4. PubMed ID: 3404235
[TBL] [Abstract][Full Text] [Related]
12. Cell kinetics of human brain tumors: in vivo study with bromodeoxyuridine and flow cytometry.
Danova M; Riccardi A; Gaetani P; Wilson GD; Mazzini G; Brugnatelli S; Buttini R; Butti G; Ucci G; Paoletti P
Eur J Cancer Clin Oncol; 1988 May; 24(5):873-80. PubMed ID: 3169092
[TBL] [Abstract][Full Text] [Related]
13. Estimation of volume doubling time and cell loss in an experimental rat glioma model in vivo.
Nakajima M; Nakasu S; Morikawa S; Inubushi T
Acta Neurochir (Wien); 1998; 140(6):607-12; discussion 612-3. PubMed ID: 9755330
[TBL] [Abstract][Full Text] [Related]
14. Impact of IUdR on Rat 9L glioma cell survival for 25-35 keV photon-activated auger electron therapy.
Alvarez D; Hogstrom KR; Brown TA; Ii KL; Dugas JP; Ham K; Varnes ME
Radiat Res; 2014 Dec; 182(6):607-17. PubMed ID: 25409122
[TBL] [Abstract][Full Text] [Related]
15. The clinical rationale for S-phase radiosensitization in human tumors.
McGinn CJ; Kinsella TJ
Curr Probl Cancer; 1993; 17(5):273-321. PubMed ID: 8281809
[TBL] [Abstract][Full Text] [Related]
16. Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations.
Begg AC; Moonen L; Hofland I; Dessing M; Bartelink H
Radiother Oncol; 1988 Apr; 11(4):337-47. PubMed ID: 3375460
[TBL] [Abstract][Full Text] [Related]
17. Differing sensitivity to fluorescent light in Chinese hamster cells containing equally incorporated quantities of BUdR versus IUdR.
Mitchell JB; Morstyn G; Russo A; Kinsella TJ; Fornace A; McPherson S; Glatstein E
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1447-51. PubMed ID: 6469768
[TBL] [Abstract][Full Text] [Related]
18. Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdR labeling indices in human brain tumors.
Nishizaki T; Orita T; Furutani Y; Ikeyama Y; Aoki H; Sasaki K
J Neurosurg; 1989 Mar; 70(3):379-84. PubMed ID: 2536805
[TBL] [Abstract][Full Text] [Related]
19. Cell proliferation of human leukemia and solid tumors studied with in vivo bromodeoxyuridine and flow cytometry.
Giordano M; Riccardi A; Danova M; Brugnatelli S; Mazzini G
Cancer Detect Prev; 1991; 15(5):391-6. PubMed ID: 1751950
[TBL] [Abstract][Full Text] [Related]
20. Correlation of histopathological features and proliferative potential of gliomas.
Germano IM; Ito M; Cho KG; Hoshino T; Davis RL; Wilson CB
J Neurosurg; 1989 May; 70(5):701-6. PubMed ID: 2709110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
